现代分娩硬膜外镇痛:对产程结局及母胎健康的影响
综述探讨现代分娩硬膜外镇痛对产程进展及母胎健康的影响。高质量研究显示硬膜外镇痛可能延长第一产程约30分钟、第二产程约15分钟,但不增加剖宫产风险;采用低浓度局麻药及程序化间歇硬膜外推注联合患者自控硬膜外镇痛可消除器械助产风险增加。现代硬膜外镇痛与产妇短暂低血压、发热相关,但未明显增加不良母胎结局。
要点
- 硬膜外镇痛可能使第一产程延长约30分钟、第二产程延长约15分钟,临床意义可能有限。
- 高质量研究一致显示硬膜外镇痛不增加剖宫产风险。
- 低浓度局麻药(≤0.1%布比卡因等效)及程序化间歇推注联合患者自控镇痛不增加器械助产风险。
核心结论
- 现代分娩硬膜外镇痛按目前理解未持续与产妇或胎儿任何显著不良结局相关。
研究设计与样本
- 综述,检索并深入复习当前关于现代分娩硬膜外镇痛应用的文献。
主要发现
- 与替代镇痛方式相比,硬膜外镇痛可使第一产程延长30分钟、第二产程延长15分钟。
- 高质量研究一致显示硬膜外镇痛与剖宫产风险增加无关。
- 部分硬膜外镇痛方式与器械助产风险较高相关,但较新方式已消除此效应。
- 等效≤0.1%布比卡因的低浓度局麻药在Meta分析中显示器械助产风险不高于非硬膜外镇痛。
- 程序化间歇硬膜外推注联合患者自控硬膜外镇痛可降低器械助产风险;2005年以来研究显示硬膜外镇痛器械助产风险不高于阿片类镇痛。
关键数值与推荐
- 低浓度局麻药溶液等效≤0.1%布比卡因。
- 2005年以来发表的研究显示硬膜外镇痛相比阿片类镇痛不增加器械助产风险(据Cochrane综述报告)。
临床怎么用
- 现代分娩硬膜外镇痛未持续与产妇或胎儿显著不良结局相关,可据此安抚提供者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epidural analgesia is an important means of pain control during labor throughout the world. Over its historic development, it has been implicated in several undesirable outcomes, including prolongation of labor and increased need for operative delivery. These effects have emerged in some retrospective and observational studies, but such methods of investigation are highly prone to bias and are particularly ill-suited for the study of labor analgesia. In high-quality studies, including Cochrane reviews and meta-analyses, epidural analgesia has been suggested to extend the first stage of labor by 30 minutes and the second stage by 15 minutes, when compared with alternative forms of analgesia. Although this may be a reproducible effect, it may be argued that it is clinically negligible. With respect to mode of delivery, similar high-quality studies have consistently shown no increased risk of cesarean delivery associated with epidural analgesia. Some forms of epidural analgesia were associated with higher risk of assisted vaginal delivery, but the use of newer modalities has been shown to abolish this effect. Specific advancements have centered on reducing total anesthetic consumption, given that local anesthetic-induced motor block is theorized to interfere with maternal expulsive efforts in the second stage of labor. These measures include the use of low-concentration local anesthetic solutions equivalent to ≤0.1% bupivacaine, shown in meta-analyses to lead to no higher risk of assisted vaginal delivery relative to nonepidural analgesia. Additional advancements in the maintenance of analgesia include programmed intermittent epidural bolus and patient-controlled epidural analgesia, the combination of which has been shown to reduce the risk of assisted vaginal delivery, also likely mediated by reduction in local anesthetic dose. These techniques have gained popularity in the past two decades, such that studies published since 2005 show no higher risk of assisted vaginal delivery with epidural than with opioid analgesia (as reported in a Cochrane review). Labor epidural analgesia has implications for maternal and fetal health perinatally. It is known to result in transient maternal hypotension (particularly with initiation), which may progress to the level of necessitating fluid or vasopressor therapy. This is not clearly associated with any adverse outcomes. There is also a consistently higher incidence of fever in parturients receiving neuraxial anesthesia, likely of noninfectious origin, which has similarly not been associated with adverse neonatal outcomes. Finally, neonates of parturients who receive epidural analgesia have been shown to have no worse Apgar scores and more favorable acid-base status than their counterparts. These observations should serve to reassure providers that modern labor analgesia, as currently understood, is not consistently associated with any significant adverse outcomes for the parturient or fetus. In this review, we describe variations of modern labor epidural analgesia, conduct an in-depth review of current literature on its use, and explore the most up-to-date evidence on its implications for the progression and outcomes of labor, including the pertinent maternal and fetal side effects.
引用
- Callahan EC, Lee W, Aleshi P, et al. Modern labor epidural analgesia: implications for labor outcomes and maternal-fetal health. Am J Obstet Gynecol. 2023. PMID: 37164496. doi:10.1016/j.ajog.2022.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。